| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 6, Issue 4 395-407, Copyright © 1995 by American Association of Cancer Research
ARTICLES |
LE Horton, Y Qian and DJ Templeton
Institute of Pathology, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA.
Inactivation of the retinoblastoma gene product (pRb) occurs concomitant with the appearance of its hyperphosphorylated form in mid to late G1. Multiple cyclin/CDK complexes are implicated in the cell cycle phosphorylation of pRb. Using in vivo expression systems, we show that cyclins A, E, D1, D2, and D3 each function to phosphorylate and inactivate pRb. In vivo, G1 cyclin/kinase complexes enhance the phosphorylation of pRb, and these effects of cyclin/kinases on pRb can be overcome by the addition of p21, a wide spectrum inhibitor of G1 kinases. Kinases associated with cyclins A, E, and D1 phosporylate pRb indistinguishably in vivo, according to proteolytic maps. Although cyclin D1 has been reported to bind to pRb directly, requiring the pRb-binding motif LXCXE, a mutant D1 lacking the pRb-binding motif remains able to phosphorylate pRb in vivo and in vitro and is also able to reverse the growth-inhibitory properties of pRb in intact cells. Finally, coexpression of G1 cyclins and kinases represses pRb-mediated growth inhibition in Saos-2 cells. The multiplicity of mechanisms for pRb phosphorylation and inactivation suggests that several pathways exist for the regulation of pRb by phosphorylation.
This article has been cited by other articles:
![]() |
C. Jacob, H. Grabner, S. Atanasoski, and U. Suter Expression and localization of Ski determine cell type-specific TGF{beta} signaling effects on the cell cycle J. Cell Biol., August 11, 2008; 182(3): 519 - 530. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Teer, Y. J. Machida, H. Labit, O. Novac, O. Hyrien, K. Marheineke, M. Zannis-Hadjopoulos, and A. Dutta Proliferating Human Cells Hypomorphic for Origin Recognition Complex 2 and Pre-replicative Complex Formation Have a Defect in p53 Activation and Cdk2 Kinase Activation J. Biol. Chem., March 10, 2006; 281(10): 6253 - 6260. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Chen, H. Pan, L. Zhu, Y. Deng, and J. W. Pollard Progesterone Inhibits the Estrogen-Induced Phosphoinositide 3-Kinase->AKT->GSK-3{beta}->Cyclin D1->pRB Pathway to Block Uterine Epithelial Cell Proliferation Mol. Endocrinol., August 1, 2005; 19(8): 1978 - 1990. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Chytil, M. Waltner-Law, R. West, D. Friedman, M. Aakre, D. Barker, and B. Law Construction of a Cyclin D1-Cdk2 Fusion Protein to Model the Biological Functions of Cyclin D1-Cdk2 Complexes J. Biol. Chem., November 12, 2004; 279(46): 47688 - 47698. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wallace and K. L. Ball Docking-Dependent Regulation of the Rb Tumor Suppressor Protein by Cdk4 Mol. Cell. Biol., June 15, 2004; 24(12): 5606 - 5619. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Chen and J. W. Pollard Cyclin D2 Compensates for the Loss of Cyclin D1 in Estrogen-Induced Mouse Uterine Epithelial Cell Proliferation Mol. Endocrinol., July 1, 2003; 17(7): 1368 - 1381. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kimura, T. Nakamura, T. Ogawa, S. Tanaka, and K. Shiota Transcription of mouse DNA methyltransferase 1 (Dnmt1) is regulated by both E2F-Rb-HDAC-dependent and -independent pathways Nucleic Acids Res., June 15, 2003; 31(12): 3101 - 3113. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. D. Brown and B. L. Gallie The B-Domain Lysine Patch of pRB Is Required for Binding to Large T Antigen and Release of E2F by Phosphorylation Mol. Cell. Biol., March 1, 2002; 22(5): 1390 - 1401. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Pan, S. Cox, R. H. Hoess, and R. H. Grafström A Cyclin D1/Cyclin-dependent Kinase 4 Binding Site within the C Domain of the Retinoblastoma Protein Cancer Res., April 1, 2001; 61(7): 2885 - 2891. [Abstract] [Full Text] |
||||
![]() |
S. Charland, M.-J. Boucher, M. Houde, and N. Rivard Somatostatin Inhibits Akt Phosphorylation and Cell Cycle Entry, But Not p42/p44 Mitogen-Activated Protein (MAP) Kinase Activation in Normal and Tumoral Pancreatic Acinar Cells Endocrinology, January 1, 2001; 142(1): 121 - 128. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. D. Brown, R. A. Phillips, and B. L. Gallie Cumulative Effect of Phosphorylation of pRB on Regulation of E2F Activity Mol. Cell. Biol., May 1, 1999; 19(5): 3246 - 3256. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. D. Adams, X. Li, W. R. Sellers, K. B. Baker, X. Leng, J. W. Harper, Y. Taya, and W. G. Kaelin Jr. Retinoblastoma Protein Contains a C-terminal Motif That Targets It for Phosphorylation by Cyclin-cdk Complexes Mol. Cell. Biol., February 1, 1999; 19(2): 1068 - 1080. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Lundberg and R. A. Weinberg Functional Inactivation of the Retinoblastoma Protein Requires Sequential Modification by at Least Two Distinct Cyclin-cdk Complexes Mol. Cell. Biol., February 1, 1998; 18(2): 753 - 761. [Abstract] [Full Text] |
||||
![]() |
T. Zarkowska and S. Mittnacht Differential Phosphorylation of the Retinoblastoma Protein by G1/S Cyclin-dependent Kinases J. Biol. Chem., May 9, 1997; 272(19): 12738 - 12746. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. N. Lavoie, G. L'Allemain, A. Brunet, R. Muller, and J. Pouyssegur Cyclin D1 Expression Is Regulated Positively by the p42/p44MAPK and Negatively by the p38/HOGMAPK Pathway J. Biol. Chem., August 23, 1996; 271(34): 20608 - 20616. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |